Transfection with MEK, ERK, JNK and p38 MAPK mutants markedly inhibited PMs-induced IL-6 and COX-II mRNA levels in RA-FLS (Figure 3C). The gene discussed is MAPK1; the disease is rheumatoid arthritis.